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AdolescentsFunctional gastrointestinal disorders (FGID), including irritable bowel syndrome, functional dyspepsia and func-
tional abdominal pain, are common in adolescents and are associatedwith substantially decreased quality of life.
Cognitive behavior therapy for children and adolescents with FGID is one of few treatments that have shown ef-
fect, but treatment access is limited. In adults with irritable bowel syndrome, exposure-based internet-delivered
CBT (ICBT) leads to reduced symptoms and increased quality of life, but studies in children are lacking. This open
pilot aimed to evaluate feasibility and the potential efﬁcacy of an exposure-based ICBT-program for adolescents
with pain-predominant FGID. Twenty-nine adolescents (age 13–17), with FGID were included. The ICBT-
program lasted for 8 weeks with weekly online therapist support. The protocol for adolescents included expo-
sure to abdominal symptoms, while the protocol for parents aimed at increasing parents' attention to adolescent
healthy behaviors. Assessment points were baseline, post-treatment and 6-month follow-up. The primary out-
comewas the Gastrointestinal Symptoms Rating Scale-IBS (GSRS-IBS). Effect sizes were calculated using Cohen's
d in an intent to treat analysis. GSRS-IBS improved signiﬁcantly frombaseline to post-treatment (mean difference
6.48; 95% CI [2.37–10.58]) and to follow-up (mean difference 7.82; 95% CI [3.43–12.21]), corresponding to mod-
erate effect sizes (within-group Cohen's d = 0.50; 95% CI [0.16–0.84] and d = 0.63; 95% CI [0.24–1.02],
respectively). Treatment adherence was high with 22 of 29 (76%) adolescents completing the entire treatment
period. High adherence indicates acceptability of format and content, while symptomatic improvement suggests
potential efﬁcacy for this ICBT intervention in adolescents with FGID.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Functional gastrointestinal disorders (FGID) are common in adoles-
cents, with a prevalence of 14% reported in Japan (Sagawa et al., 2013)
and as much as 24% reported in an often cited school-based study
(Saps et al., 2009). FGID are associated with school absenteeism, highunctional abdominal pain; FD,
orders; CBT, cognitive behavior
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. This is an open access article underhealth care consumption, increased anxiety and depression (Saps
et al., 2009) and have a large negative impact on the quality of life
(Youssef et al., 2006). Three of themost common types of FGID are irri-
table bowel syndrome (IBS), functional abdominal pain (FAP), and func-
tional dyspepsia (FD) (Sagawa et al., 2013). They are characterized by
recurrent abdominal pain or discomfort and in IBS, also a change in
defecation patterns and consistency (Rasquin et al., 2006). Other gastro-
intestinal symptoms like nausea, bloating, and ﬂatulence are also com-
mon in FGID (Rasquin et al., 2006). FGID symptoms have been shown
to be stable over time (Walker et al., 1998) and sustain into adulthood
for many patients (Campo et al., 2001). There is currently no support
that medical or dietary treatments have any meaningful beneﬁcial
effects (Huertas-Ceballos et al., 2008, 2009) but cognitive behavior
therapy (CBT) has been evaluated for children and adolescents with
FGID with promising results (Foisy et al., 2011; Sprenger et al., 2011).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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there is a shortage of CBT therapists (Shafran et al., 2009). During the
last two decades, internet-delivered CBT (ICBT) has been applied to
more than 20 different clinical disorders in adults in more than 100
studies with results equivalent to traditional CBT (Hedman et al.,
2012). While ICBT treatments are often based on the same therapeutic
content as face-to-face CBT, the content is presented online and patients
and therapists interact using written messages. Thus, ICBT can poten-
tially increase the availability of effective psychological treatments
through reduced therapist time per patient and greater geographical
reach. Although themajority of ICBT studies have included adult partic-
ipants, ICBT has been shown to lead to improvement for children and
adolescents suffering from anxiety disorders (Richardson et al., 2010;
Vigerland et al., 2013), OCD (Lenhard et al., 2014), chronic pain (Hicks
et al., 2006; Palermo et al., 2009), and other health problems (Cushing
& Steele, 2010). However, although studies of ICBT for children and ad-
olescents with chronic pain have included participants with abdominal
pain, among other pain conditions, these treatments have not been
designed to speciﬁcally target the full range of symptoms in FGID, for
example disturbed defecation in IBS, and dyspeptic symptoms in FD
(Rasquin et al., 2006). Thus, it has not been investigated if ICBT tailored
speciﬁcally for FGID could lead to global symptom relief.
Many CBT protocols for abdominal pain rely on interventions that
target stress or teach symptom management techniques, such as
applied relaxation, deep breathing and distraction (Sprenger et al.,
2011). These interventions are often based on the common observation
that abdominal pain is associated with stress (Song et al., 2012).
However, studies of adults with IBS have indicated that fear and avoid-
ance of symptoms rather than stress may be the most important factor
associated with diminished quality of life and symptom severity
(Hazlett-Stevens et al., 2003; Labus et al., 2004, 2007; Jerndal et al.,
2010; Reme et al., 2010). Thus, instead of aiming at symptom improve-
ment through symptom control and stress reduction, another target of
treatment could be to use exposure treatment i.e., to practice having
symptoms in difﬁcult situations, to reduce the fear of symptoms and
avoidance behaviors, and to ultimately reduce symptoms. Several stud-
ies have shown that exposure treatment is effective for reducing gastro-
intestinal symptoms in adults with IBS, both in face-to-face format
(Ljótsson et al., 2010a; Craske et al., 2011) and delivered over the inter-
net (Hunt et al., 2009; Ljótsson et al., 2010b, 2011a,b, 2014). In these
studies, the exposure-based ICBT has targeted avoidance behaviors
and fears that are related to both the abdominal pain and the disturbed
defecation in IBS.
In summary, no previous study has investigated ICBT speciﬁcally
tailored for adolescents with FGID and neither has any study investigated
the effect of exposure-based CBT, regardless of delivery format, for FGID
in adolescents. As preparation for a planned randomized controlled
trial, we therefore conducted this open pilot trial to evaluate the feasi-
bility and potential efﬁcacy of a newly developed internet-delivered
exposure-based CBT for adolescents diagnosed with pain-related
FGID, speciﬁcally IBS, FAP or FD.
2. Methods
2.1. Design
Thiswas an open pilot trialwith no control group. All adolescents re-
ceived the same exposure-based ICBT with therapist support during
8 weeks. One parent of each adolescent also participated in a parallel
parent-training program during the 8 weeks. The adolescents were
assessed at baseline (1 week before treatment), post-treatment (after
8 weeks), and at 6 months follow-up. The adolescents were asked to
complete the post-treatment and follow-up assessments regardless of
the number ofﬁnishedmodules.We aimed to recruit 25–30 adolescents
to achieve a power of at least 80% to detect a within-group effect size
of Cohen's d= 0.6 on the primary outcome measure, i.e., a moderatetreatment effect (Cohen, 1992). This study is reported according to
the TREND Statement Checklist for nonrandomized interventions
(Jarlais et al., 2011). The study was approved by the Regional Ethical
Review Board in Stockholm in December 2011 and is registered on
clinicaltrials.gov (reg.no: NCT02033161).
2.2. Eligibility criteria
Eligibility criteria were age 13–17 years, residence in Stockholm
County and referral to the study by a treating physician. Moreover, the
adolescent and at least one parent had to have easy access to the internet,
sufﬁcient computer experience, andbe able to read andwrite in Swedish.
Adolescents were not included if there were any concurrent serious
medical condition or gastrointestinal organic disorder, any psychiatric
disorder that required immediate treatment or psychiatric examination,
any current psychological treatment, school attendance less than 80%
(because a high absence from schoolwas judged to require amore inten-
sive intervention), or on-goingmaltreatment, violence or severe parental
psychiatric illness in the family.
2.3. Procedure and referral
Fifty-ﬁve adolescents and their parents were referred to the study
from specialized pediatric clinics in the greater Stockholm urban area.
Within this group 46 families declared interest to participate in the
study and underwent a screening interview performed by a psycholo-
gist (MB). The treating physician referred the adolescents to the study
by consulting a pediatric gastroenterologist (OO) ensuring that the
patient had been clinically diagnosedwith FGID and that he/she had ab-
dominal pain at least everyweek for at least the two lastmonths (i.e. the
requirements for pain frequency and duration according to the Rome III
criteria for IBS, FAP or FDwere fulﬁlled). The treating physician also had
to ensure that all the following investigations had been normal: growth
during childhood, IgA-tissue tranglutaminase, complete blood count,
erythrocyte sedimentation rate or C-reactive protein analysis, liver
enzymes, and fecal calprotectin (Rasquin et al., 2006). At the screening
interview, the phenotype of FGID at study entry (i.e. IBS, FD or FAP)
was established using the Rome III criteria (Rasquin et al., 2006). Of
the interviewed adolescents, 29 met all eligibility criteria and entered
the study. The participants were recruited and treated in two cohorts,
12 families were assessed at baseline in April 2012 with post-
treatment assessments in June and 6 months follow-up in December,
and 17 families were assessed at baseline in September 2012 with
post-treatment assessments in November and 6 months follow-up in
May 2013. All outcome measures were completed by the adolescents
and were conducted online. See Fig. 1 for participants ﬂow through
the study. Parents and adolescents gave written informed consent for
participation in the study at the inclusion interview. No compensation
was paid for participation.
2.4. Measures
2.4.1. Primary outcome measure
The primary outcome measure was the Gastrointestinal Symptom
Rating Scale-IBS version (GSRS-IBS), that includes 13 items about how
bothersome gastrointestinal symptoms have been during the past
week, e.g., bloating, diarrhea, constipation, early satiety/dyspepsia and
abdominal pain (Wiklund et al., 2003). Although developed primarily
for IBS, the GSRS-IBS also includes questions about abdominal pain
(the main symptom of FAP) as well as early satiety and prolonged
fullness (symptoms of FD). The GSRS-IBS has excellent psychometric
properties with internal consistency between α= .74 (for abdominal
pain) and α= .85 (for satiety) in adults (Wiklund et al., 2003). The
GSRS-IBS has not been validated for adolescents, but there are few alter-
nativemeasures for adolescents that include the full range of abdominal
symptoms present in pain-related FGID.
Assessed for eligibility
(n= 46) Excluded (n=17): Due to psychiatric disorder that required 
immediate treatment or psychiatric examinaon (n=7), 
current psychological treatment (n=1), school aendance 
less than 80% (n=1), and conﬂict in family (n=2).
Declined to parcipate due lack of movaon because of no 
current symptoms (n=5) and no reason given (n=1).In treatment
(n=29)
Non-completers (n=7): 
Withdrew due to lack of 
me (n=2) and due to 
computer-problems (n=1).
Completed less than four 
modules (n=4)
Completed treatment
(n=22)
Completed post-treatment 
assessment 
(n=27)
Completed 6-month follow-
up assessment 
(n=26)
Referred to study from 
pediatrician 
(n=55) Not assessed (n=9): not 
interested (n=3), could not 
be reached (n=6).
Analyzed 
(n=29)
Fig. 1. Participants' ﬂow through the study.
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Pain Reactivity Scale (PRS) is a self-rating scale designed for children
and adolescents with chronic pain, andmeasures the concern and focus
on the pain. The form consists of ﬁve questions that are graded on a
scale from1 (“not at all”) to 6 (“verymuch”). Three items are about feel-
ings and thoughts about worry of pain. Two items relate to worry about
not being able to do things because of pain. PRS has satisfactory psycho-
metric properties (Wicksell et al., 2011).
Pain Interference Index (PII) is a self-rating scale that measures
interference on function because of pain in children and adolescents. It
consists of six questions concerning how much the respondent has
been inﬂuenced by their discomfort in various activities, such as “Has
your problemmeant that it has been hard to spend time with friends?”.
Questions are answered on a 6-point scale from 0 (“not at all”) to 6
(“very much”). Preliminary analysis shows satisfactory psychometric
properties (Wicksell et al., 2011).
Functional Disability Inventory (FDI) measures the difﬁculty in
performing everyday activities (Walker & Greene, 1991). It consists of
15 questions that concern speciﬁc activities like climbing stairs, running
100 m and going shopping, and general activities such as helping out at
home, eatingmeals and being in school all day. The scale ranges from 1
(no problem at all) to 5 (impossible). It is an often used instrument in
pain studies in children and is validated for children and adolescents
with chronic abdominal pain with high internal consistency, α= .86
for boys and α= .91 for girls (Claar & Walker, 2006). FDI is the scale
recommended in pediatric pain studies to measure the impact on func-
tion (McGrath et al., 2008).
Childhood Anxiety Sensitivity Index (CASI) consists of 18 items on a
3-point scale (1–3), which measures sensitivity to internal sensationsthat could be symptoms of anxiety. The 18 questions include items
like “It scares me when I feel ‘shaky’” or “It scares me when my heart
beats fast” as well as items directly relevant to a FGID population as
“When my stomach hurts, I worry that I might be really sick”. The
scale has high reliability, Cronbach's α= .84 (Silverman et al., 1991).
Child Depression Inventory (CDI) is a depression scale for children
(Kovacs, 1992) and consists of 27 items (0–2 p), each with three state-
ments of varying severity, such as: “I am sad once in a while,” “I'm often
sad” or “I am sad all the time.” Respondents are instructed to select the
option that best matches their experience over the last two weeks. A
clinical cut-off for mild depression at 19 points has been suggested
(Friedberg & Sinderman, 2011). Psychometric properties have been
validatedwith acceptable internal consistency, Cronbach's alpha between
α= .83 and α= .89 (Smucker et al., 1986).
Perceived Stress Scale (PSS) is a widely used self-assessment ques-
tionnaire (1983) to measure perceived stress. PSS-4 is a short version
of the original, and consists of four statements about the feeling of
being able to handle problems that need to be addressed. Responses
are rated from 0 (“never”) to 4 (“very often”). Reliability for the version
with 4 items is α= .72 (Cohen et al., 1983).
2.5. Intervention
2.5.1. Target and content
The treatment was a revised version of a protocol used in previous
studies on adults with IBS (Ljótsson et al., 2010a,b, 2011a,b, 2014).
The main changes included shorter texts, a simpliﬁed language, a color-
ful design, illustrations and photographs, audio ﬁles, examples based on
young people's experiences of having a FGID and an addition of a
144 M. Bonnert et al. / Internet Interventions 1 (2014) 141–148parent-training protocol. Before the pilot study was launched, we treat-
ed ﬁve adolescents and their parents in traditional face-to-face format
to evaluate and develop different elements of the protocol. The treat-
mentwas separated into sixmodules that the participantswere granted
gradual access to during 8 weeks.
Module one included education about FGID and a presentation of 3
ﬁctive adolescents with IBS, FD and FAP respectively. These ﬁctive ado-
lescents were included in all modules to serve as examples for the three
diagnoses andhow exposure exercises could be performed. A treatment
model was introduced explaining how FGID-speciﬁc behaviors, aimed
at controlling and reducing FGID symptoms, in the long run could
maintain and even reinforce symptoms. In this module the participants
identiﬁed their individual symptoms and how they limited everyday
activities in terms of control and avoidance behaviors. An exercise in
mindfulness that facilitated interoceptive exposure for abdominal
symptoms was assigned as homework.
In the second module, after a detailed review of individual
symptom-related behaviors, the participants were introduced to
behavior analysis in a three-step-model, the Antecedent–Behavior–
Consequence model (A–B–C), with long-term consequences of FGID-
speciﬁc behaviors explained through an example of an adolescent
with IBS. After completing an individual analysis on their own common
FGID behaviors, the participants chose an alternative behavior to test
during the coming week. This behavior experiment aimed at challeng-
ing symptom-catastrophizing as a precursor for later exposuremodules.
In module three participants were taught an exercise in acceptance
of abdominal symptoms. Participants who had high-frequency use of
the toiletwere introduced to an exercise to reduce their number of toilet
visits, by postponing urgent toilet visits by a fewminutes and by follow-
ing a schedule to avoid numerous visits triggered by discomfort. This
exercise aimed at reducing the reinforcing effect of immediate toilet
visits following signs of FGID symptoms, and to establish a routine for
normal toilet habits. Participants who had no unusual toilet behavior
but used other problematic high-frequency behavior, like swallowing,
drinkingwater or spitting to control nausea, or rest to reduce abdominal
pain, were encouraged to reduce this instead.
Module 4 explained in detail how to conduct exposure to gastrointes-
tinal symptoms. In preparing for exposure exercises, i.e. exercises to vol-
untarily perform behaviors that provoked symptoms, the participantsPart 1: On FGID and 
symptoms
Part 2: Parental 
behavior and 
child symptoms
Part 1: On FGID and 
symptoms
Part 2: My 
FGID-
behaviors
Part 3: 
Acceptance & 
toliet habits
Week 1 w. 2 w. 3 w. 
Week 1 w. 2 w 3 w. 4 w
Adolescent protocol
Parent protocol
FGID = Functional gastrointestinal disorder
Fig. 2. Outline ofmade an individual hierarchy of difﬁcult situations that normally elicited
symptoms and planned alternative behavior in response to the symp-
toms that these situations could elicit. This meant that the treatment en-
couraged participants to fully engage in activities that could produce
gastrointestinal symptoms without trying to control the symptoms.
In the ﬁfth module the exposure continued with the addition to
deliberately increase the symptoms, for example by eating large
amounts of food that previously were avoided to control gastrointesti-
nal symptoms, and enter situations in which the elicited symptoms
would be perceived as difﬁcult to accept. This systematic exposure
aimed to reduce fear of having symptoms, which in turn would lead
to reduced symptoms and improved functioning. It was explained that
by this intensive exposure, the fear of symptoms would no longer be
maintained by “threshold thinking” where symptoms would be tolera-
ble only as long as they did not exceed a certain level. Instead partici-
pants would get to experience that they could have a lot of symptoms
and still function reasonably. Participants worked with these exercises
until the last week of treatment when module six was introduced,
which was dedicated to relapse prevention.
Parents received four modules over 8 weeks. The ﬁrst module
consisted of psycho-education about FGID and the treatment model
and increased positive time with the child in order to reduce attention
to pain. Module two targeted how parental response to the child's
symptom might function to maintain symptom severity and focused
on individualized behavior modiﬁcation in order to counteract this.
Module three included the rational for their child's work with exposure
to symptoms and suggestions on how the parent could support their
child during the exposure. Module four was a relapse prevention plan.
See Fig. 2 for outline of content and timing of both the adolescent and
parent treatment protocols.
2.5.2. Therapist contact
During treatment, participants had contact with one of three thera-
pists, of which one was an experienced licensed psychologist (MB)
and two were CBT-trained ﬁnal year psychology students under super-
vision. The treatment contact was conducted over a secure internet
platform developed speciﬁcally to deliver ICBT. Participants completed
worksheets to report their work with the treatment, and their therapist
provided weekly written feedback. Participants could also initiatePart 3: Support 
exposure
Part 4: Relapse 
prevenon
Part 4: 
Exposure for 
symptoms
Part 5: More 
exposure
Part 6: 
Relapse 
prevenon
4 w. 5 w. 6 w. 7 w. 8
. 5 w. 6 w. 7 w. 8
treatment.
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for speciﬁc questions about the ongoing treatment, and the therapists
responded to messages within two working days. The messages that
therapists sent to participants, for examplewith feedback on homework
exercises or responses to inquiries, were notwritten in accordancewith
a speciﬁc manual. However, the content published on theweb platform
was ﬁxed, which ensured that the participants were exposed to the
same main treatment content. All participants also received one tele-
phone call from their therapist during the ﬁfth and sixth weeks of treat-
ment to provide encouragement and discuss how to conduct the
exposure exercises. These telephone callswere not logged and the treat-
ment platform did not allow for timing of therapist time spent per
participant.
2.6. Analysis
To make use of all available data in an intent-to-treat analysis, we
used the multiple imputation procedure in SPSS 20 to impute missing
sum scores for study dropouts at the post-treatment and follow-up
assessments. All estimates (i.e., means, standard deviations, effect
sizes, standard errors, and conﬁdence intervals) were calculated for
each of ﬁve imputations and then combined into pooled estimates
according to “Rubin's rules” (Rubin & Schenker, 1991) and the small
sample correction for pooled degrees of freedom (Barnard, 1999).
Two-tailed dependent Student's t-testswere performed to detect signif-
icant within-group differences between baseline and post-treatment,
and between baseline and 6-month follow-up. Effect sizes and 95% con-
ﬁdence intervals of changes between assessments were calculated as
within-groups d (Borenstein et al., 2011) i.e., the standardizedmean dif-
ference. Effect sizes were categorized according to Cohen's suggestion
where small, medium, and large effect sizes are d ≥ 0.20, 0.50, and
0.80, respectively (Cohen, 1992).
3. Results
3.1. Description of sample
Participants in the pilot study consisted of 29 adolescents living in
Stockholm, themajority were girls (n=22; 76%). Nineteen adolescents
(66%) were diagnosed with IBS while 5 (17%) adolescents had FD and 5
(17%) had FAP diagnoses. The majority of parents that participated in
the parent-training program were female (n= 26; 90%).
3.2. Completion rates
The ﬁfth module did not introduce new treatment content but en-
couraged continued exposure and the last module only covered relapse
prevention. Thus, we considered participants who had completed at
least four modules to have been exposed to the full therapeutic contentTable 1
Self-assessments at pre-treatment, post-treatment and 6-month follow-up.
Pre-treatment Post-treatment Pre- to post-treatment co
m (SD) m (SD) t df d [9
GSRS-IBS 33.72 (13.62) 27.25 (12.00) 3.24⁎ 26.1 0.50
PRS 16.21 (7.26) 10.99 (6.83) 4.91⁎ 25.9 0.74
PII 13.97 (8.91) 10.77 (8.90) 3.04⁎ 25.4 0.36
FDI 23.59 (7.30) 21.32 (5.69) 1.81 26.0 0.34
CASI 32.24 (7.23) 30.88 (6.34) 1.51 26.1 0.20
CDI 9.00 (5.57) 8.44 (6.28) 0.80 25.4 0.09
PSS 4 6.28 (3.14) 5.18 (3.19) 2.24⁎ 23.7 0.35
Note: All estimates and test-statistics are based on pooling of multiple (n = 5) imputations. Abb
PRS = Pain Reactivity Scale (range 0–30); PII = Pain Interference Index (range 0–36); FDI = F
(range 18–54), CDI = Child Depression Inventory (range 0–54), PSS 4 = Perceived Stress Scal
d), t = t-value of dependent t-test, df = degrees of freedom.
⁎ p b .05 of dependent t-test.of the treatment and thus as treatment completers. Twenty-two adoles-
cents (76%) ﬁnished four or all six modules of the treatment, four (14%)
adolescents lagged behind and completed less than two modules, and
three (10%) adolescents actively withdrew from treatment (two due
to lack of time and onedue to computer-problems). On average, parents
participated in the treatment to the same extent as their child. Attrition
rates were low, 27 adolescents (96%) completed the assessments at
post-treatment and 26 (93%) completed the 6-month follow-up.
3.3. Results on outcome measures
Means, standard deviations, p-values of dependent t-tests, and effect
sizes (d) with 95% conﬁdence intervals are reported in Table 1. All effect
sizes reported in text are statistically signiﬁcant at the 95% level. Partic-
ipants showed signiﬁcant improvement in gastrointestinal symptoms,
asmeasured by the primary outcomemeasure GSRS-IBSwithmoderate
effect sizes at post-treatment and 6-month follow-up compared to
baseline (d=0.50 and 0.63, respectively).Worry about pain symptoms,
as measured by PRS, was signiﬁcantly improved immediately after
treatment with a moderate to large effect size (d= 0.74). The follow-
up suggested further improvement with a large effect size (d= 1.05).
Pain interfering with function was not much improved directly after
treatment, as shown by PII with a small effect size (d= 0.36), however
the pre-to 6-month follow-up effect size was moderate to large
(d = 0.76). The same pattern was noted for increased function as
measured by FDI, with a non-signiﬁcant change at post-treatment and
a moderate effect at follow-up (d = 0.57). This was also the case for
sensitivity to inner symptoms of anxiety as measured by CASI, a non-
signiﬁcant change at post-treatment and a moderate effect at follow-
up (d = 0.44). Effects on the levels of perceived stress (PSS-4) and
depressive symptoms (CDI) were small or non-signiﬁcant at both post-
treatment and 6-month follow-up assessments.
4. Discussion
The objective of the present pilot study was to investigate the feasi-
bility and potential efﬁcacy of an internet-delivered cognitive behavior-
al treatment, primarily based on exposure exercises, for adolescents
diagnosed with IBS, FAP or FD. The high adherence and low attrition
rates indicate that the treatment is feasible for its target population.
Results showed signiﬁcant and moderate treatment effects on the pri-
mary outcome measure, GSRS-IBS, that were stable 6 months after
treatment. To our knowledge, this is the ﬁrst study of its kind for this
population, both in terms of delivery format and treatment content.
The pronounced effects observed on PRS, are in line with the pro-
posed treatmentmechanisms (i.e. reduced avoidance leads to decreased
fear of symptoms, which in turn leads to symptom improvement). The
design of our study does not allow for any investigation of this as a pro-
posed mechanism, but a mediational study of the exposure-based ICBTmparison 6 mo follow-up Pre- to 6 mo follow-up comparison
5% CI] m (SD) t df d [95% CI]
[0.16, 0.84] 25.90 (10.47) 3.67⁎ 25.6 0.63 [0.24, 1.02]
[0.39, 1.09] 9.35 (5.48) 5.00⁎ 25.5 1.05 [0.59, 1.59]
[0.11, 0.61] 7.48 (7.92) 4.98⁎ 25.9 0.76 [0.41, 1.12]
[−0.06, 0.74] 19.99 (4.90) 2.67⁎ 25.9 0.57 [0.10, 1.04]
[−0.07, 0.47] 29.18 (6.50) 2.61⁎ 25.2 0.44 [0.08, 0.81]
[−0.15, 0.33] 8.00 (6.68) 1.12 24.6 0.16 [−0.14, 0.46]
[0.02, 0.69] 5.25 (3.42) 1.60 21.0 0.31 [−0.10, 0.73]
reviations: GSRS-IBS = Gastrointestinal Symptom Rating Scale-IBS version (range 13–91);
unctional Disability Inventory (range 15–75); CASI = Childhood Anxiety Sensitivity Index
e 4 item version (range 0–16); d = within-group standardized mean difference (Cohen's
146 M. Bonnert et al. / Internet Interventions 1 (2014) 141–148for adultswith IBS showed that reduction in fear and avoidance of symp-
tomswere associatedwith and preceded improvement in IBS symptoms
(Ljótsson et al., 2013), indicating that the same mechanisms of change
may have been active in this trial. The low and non-signiﬁcant effects
on function, as measured by PII and FDI, seemed to increase at follow-
up. In general, lowor non-signiﬁcant effectswere observed onmeasures
of anxiety sensitivity, stress and depression. The average pre-treatment
scores on the measures of stress and depression, PSS 4 and CDI, were
below clinical ranges (Ivarsson et al., 2006; Warttig et al., 2013), but
the pre-treatment anxiety scores, CASI, were comparable to clinical
populations (Chorpita & Lilienfeld, 1999). This indicates that while the
ICBT might lead to symptom improvement and reduced worry about
symptoms, it does not seem to address clinical levels of anxiety
sensitivity.
The moderate within-group effect size on the GSRS-IBS was notably
lower than the large effects that internet-delivered exposure treatment
has shown on GI symptoms in adults with IBS (Ljótsson et al., 2010b,
2011a,b, 2014). However, there were important differences between
this study and the previously conducted studies on adult patient sam-
ples. In one of the studies (Ljótsson et al., 2010b), the adults with IBS
in the treatment condition reported a mean of 48.5 (SD = 8.8) on the
GSRS-IBS at baselinewhichwas reduced to 32.4 (SD= 12.1) after treat-
ment. In the present study, the mean baseline GSRS-IBS score was 33.7
(SD = 13.6), which is quite close to the average post-treatment symp-
tom burden in the adult trial. A lower initial symptomburden allows for
less improvement, which may have affected the observed effect sizes.
Reporting fewer or less bothersome gastrointestinal symptoms could
partly be an effect of age; young people may not have developed as
severe symptoms as adults.
Given the novelty of the treatment content and delivery format, it is
encouraging to note that our study shows similar results as the largest
randomized study of face-to-face CBT so far conducted in children
with functional abdominal pain (Levy et al., 2010). Levy and colleagues
reported moderate between group-effects on pain and a moderate
within-group increase in the level of function after a brief 3-session
CBT-intervention focused on parental behavior, relaxation and im-
proved coping. Our treatment, on the other hand, was based on expo-
sure exercises to gradually decrease the fear of symptoms and
avoidance behaviors. ICBT based on stress reduction, relaxation, and
symptom management, has also been tried for adolescent abdominal
pain with large effects on pain intensity (Hicks et al., 2006; Palermo
et al., 2009). However, the studies by Hicks (Hicks et al., 2006) and Pa-
lermo (Palermo et al., 2009) did not exclusively include adolescents
with an FGID and did not report effects on gastrointestinal symptoms
other than pain. In contrast, we included only patients with pain-
related FGID: IBS, FAP, and FD in this pilot trial and our main outcome
measure, the GSRS-IBS, captures the total symptom burden of all these
diagnoses, including abdominal pain, bloating, disturbed defection,
and dyspepsia. Thus, our results suggest that ICBT based on exposure
exercises may produce global symptom relief in FGID, with effects
similar to those obtained in pain-focused CBT based on relaxation and
coping strategies.
A recentmeta-analysis has questioned the involvement of parents in
CBT for anxiety in children, showing no added effectwhen parents were
involved in treatment (Thulin et al., 2014). In our treatmentwe chose to
involve the parents with a speciﬁc parent training protocol, since the
literature is rich on examples of how parent behavior might inﬂuence
childrens pain and illness behavior (Whitehead et al., 1982; Levy et al.,
2004, 2007; Jellesma et al., 2008) and traditional CBT targeting parent
behavior has been shown to relieve their children's symptoms (Levy
et al., 2010). Because we were testing a new exposure-based interven-
tion, it also seemed appropriate to provide the parents with a rationale
for the often-times difﬁcult exercises that their child would perform.
The most important limitation of this pilot study is the lack of
randomization to a control group, limiting the internal validity of the
study. We cannot therefore separate the treatment effects from otherimportant factors that may affect symptom levels, for example, sponta-
neous improvement, seasonal variation in symptoms, regression to the
mean or non-speciﬁc therapeutic elements such as attention from a
caregiver and hope of improvement. However, as the time period be-
tween baseline and post-treatment was short and the effect sizes on
the primary outcome were fairly large we view the ﬁndings as encour-
aging and unlikely to be fully explained by other factors than the treat-
ment. The choice of a primary outcome measure that has not been
validated for adolescents is an important limitation. Other measures of
adolescent GI symptoms that were available had other important draw-
backs, for example, the questionnaire on pediatric gastrointestinal
symptoms (QPGS) (Caplan et al., 2005) is quite extensive and the
Child somatization Inventory (CSI) (Walker et al., 2009) has not been
validated as a measure of change in gastrointestinal symptoms. In con-
trast, the GSRS-IBS is brief and has been responsive to treatment in our
studies of ICBT for IBS in adults. A separate measure of pain in addition
to the GSRS-IBS would also have been desirable to allow for comparison
of the results with previous studies of CBT for adolescents with FGID.
This study is also limited by the lack of relevant background data
about the participants. More information should have been collected
and reported about family structure, IBS subtype, and duration of illness.
Furthermore, we did not measure if there were any adverse effects of
the treatment. The potential adverse effects of psychological treatments
are generally believed to be insufﬁciently studied (Nutt & Sharpe, 2008;
Barlow, 2010). Exposure interventions are seldom part of psychological
treatments for FGID in children and adolescents, which may be partly
explained by the fact that somemental health professionals view expo-
sure as unethical, unsafe and ineffective (Meyer et al., 2014). The ICBT
format could also make the exposure exercises harder to perform prop-
erly for the patient, because the online therapist has less information
about how the exposure exercises are conducted (Rozental et al.,
2014). To learn more about how FGID patients react to exposure exer-
cises in an ICBT context, it would have been preferable if adverse events
had been monitored and reported.
5. Conclusions
Exposure-based ICBTmay be a feasible and efﬁcacious treatment for
adolescents diagnosed with IBS, FAP or FD. The results obtained in this
pilot study will be used in the planning of future randomized controlled
trials, required to conﬁrm these preliminary results. The internet-
modality is particularly interesting as it allows any geographical
distance between patient and therapist and could potentially be used
to increase accessibility to effective psychological treatment for this
patient group.
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